Bing Xian Liu
Amministratore Delegato presso Konfoong Biotech International Co., Ltd.
Posizioni attive di Bing Xian Liu
Società | Posizione | Inizio | Fine |
---|---|---|---|
Konfoong Biotech International Co., Ltd.
Konfoong Biotech International Co., Ltd. Medical SpecialtiesHealth Technology Konfoong Biotech International Co., Ltd. is a high-tech bio-information technology enterprise based in China. The Chinese company has built numerous pathology teleconsultation platforms, including several provincial centers nationwide, and its digital pathology products have been implemented in almost 1,000 hospitals across the country. Konfoong Biotech has also been actively incorporating artificial intelligence technology to promote product innovation and has launched over 10 artificial intelligence-aided pathology diagnosis projects, such as cervical fluid-based cytology, liver pathology, kidney pathology, and breast pathology, to develop intelligent pathology-aided diagnosis systems. The company was founded in 2011 by Bing Xian Liu, who has been the CEO since then. | Amministratore Delegato | 04/08/2011 | - |
Presidente | 04/08/2011 | - | |
Fondatore | 04/08/2011 | - |
Storia della carriera di Bing Xian Liu
Statistiche
Distribuzione geografica
Cina | 2 |
Posizioni
Chief Executive Officer | 1 |
Chairman | 1 |
Founder | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Konfoong Biotech International Co., Ltd.
Konfoong Biotech International Co., Ltd. Medical SpecialtiesHealth Technology Konfoong Biotech International Co., Ltd. is a high-tech bio-information technology enterprise based in China. The Chinese company has built numerous pathology teleconsultation platforms, including several provincial centers nationwide, and its digital pathology products have been implemented in almost 1,000 hospitals across the country. Konfoong Biotech has also been actively incorporating artificial intelligence technology to promote product innovation and has launched over 10 artificial intelligence-aided pathology diagnosis projects, such as cervical fluid-based cytology, liver pathology, kidney pathology, and breast pathology, to develop intelligent pathology-aided diagnosis systems. The company was founded in 2011 by Bing Xian Liu, who has been the CEO since then. | Health Technology |
- Borsa valori
- Insiders
- Bing Xian Liu
- Esperienza